Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$27.64 USD
-0.65 (-2.30%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $27.56 -0.08 (-0.29%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 0.02 |
EPS Last Quarter | 0.05 |
Last EPS Surprise | 600.00% |
ABR | 2.36 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.10 |
Next Year | 0.31 |
EPS (TTM) | 0.05 |
P/E (F1) | 285.93 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 208.24M | 218.29M | 840.22M | 922.25M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 210.00M | 221.85M | 841.20M | 934.83M |
Low Estimate | 204.53M | 216.44M | 838.96M | 909.62M |
Year ago Sales | 191.90M | 196.60M | 753.20M | 840.22M |
Year over Year Growth Est. | 8.52% | 11.03% | 11.55% | 9.76% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.02 | 0.04 | 0.10 | 0.31 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | 0.00 | 0.05 | 0.09 | 0.43 |
High Estimate | 0.06 | 0.05 | 0.10 | 0.49 |
Low Estimate | 0.00 | 0.03 | 0.09 | 0.15 |
Year ago EPS | -0.03 | 0.04 | -0.27 | 0.10 |
Year over Year Growth Est. | 166.67% | 0.00% | 137.04% | 216.66% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 3 | 1 | 8 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.02 | 0.04 | 0.10 | 0.31 |
7 Days Ago | 0.02 | 0.04 | 0.10 | 0.31 |
30 Days Ago | 0.02 | 0.04 | 0.09 | 0.30 |
60 Days Ago | 0.00 | 0.04 | -0.11 | 0.10 |
90 Days Ago | 0.00 | 0.04 | -0.11 | 0.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.02 | 0.03 | 0.10 | 0.33 |
Zacks Consensus Estimate | 0.02 | 0.04 | 0.10 | 0.31 |
Earnings ESP | 0.00% | -14.29% | 3.45% | 3.73% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.05 | -0.01 | 0.04 | -0.03 | NA |
Estimate | -0.01 | -0.11 | 0.02 | -0.08 | NA |
Difference | 0.06 | 0.10 | 0.02 | 0.05 | 0.06 |
Surprise | 600.00% | 90.91% | 100.00% | 62.50% | 213.35% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more